Try our Advanced Search for more refined results
Health
-
January 29, 2026
DOL Proposes Pharmacy Benefit Manager Fee Disclosure Rule
The U.S. Department of Labor's employee benefits subagency Thursday proposed a rule to require new fee disclosures from pharmacy benefit managers, which act as intermediaries between drugmakers, pharmacies and insurers, to help managers of employee health plans ensure PBM services are reasonably priced.
-
January 29, 2026
Pa. Nursing Home Disputes Patient Death Suits' Coverage Cap
A Pennsylvania nursing home told a federal court that an insurer should pay up to $3 million in coverage for lawsuits by six patients' estates alleging a staff member murdered them, arguing the insurer misconstrued a state medical negligence statute in order to limit coverage.
-
January 29, 2026
Conn. Drug Price Cap Survives Distributor Challenge, For Now
The Second Circuit has declined a bid to immediately block the state of Connecticut from enforcing a cap on generic and off-patent drug prices while the Healthcare Distribution Alliance, a collection of wholesale distributors, challenges the new law.
-
January 29, 2026
ITC To Review Medical Imaging Imports For Infringement
The U.S. International Trade Commission said it is looking into medical imaging device imports for alleged patent infringement in response to a complaint from a Canadian-American firm.
-
January 29, 2026
Teva Tries To Spike Paragard Trial Claims, Punitive Damages
About a week into its first trial over the alleged dangers of the Paragard contraceptive, Teva Pharmaceuticals asked a Georgia federal judge Wednesday to cut the case short and hand it an early win, or at least let it out of a bid for punitive damages.
-
January 29, 2026
United Healthcare Beats Class Cert. Bid Over Breast Surgery
A New Jersey federal judge on Wednesday declined to certify a proposed class of United Healthcare Insurance plan participants who were denied coverage for post-mastectomy breast reconstruction surgery, finding that she can't determine which standard of review applies to each plan's varying language without conducting individualized, fact-specific inquiries.
-
January 29, 2026
Inspire Medical Leaders Face Suit Over Apnea Device Rollout
Brass of Inspire Medical Systems Inc. face shareholder derivative claims they breached their fiduciary duties by concealing issues affecting the launch of the company's latest sleep apnea device, damaging investors after its trading prices fell 32% when the issues were disclosed.
-
January 29, 2026
Sandoz, Teva Beat Malicious Prosecution Claims, For Now
Sandoz and Teva have won a reprieve from a former pharmaceutical marketing executive claiming the drugmakers and their officers offered him up to federal prosecutors with fabricated assertions of price-fixing, with a New York federal judge concluding the suit "does not come close" to the standard for malicious prosecution.
-
January 29, 2026
Nurse Fired In Pandemic-Era RIF Can't Reinstate Age Bias Suit
The Sixth Circuit backed the dismissal of an age bias suit from a nurse who claimed a medical center used a COVID-19-related reduction in force as an excuse to fire her, ruling a supervisor calling one of her colleagues a "young star" wasn't linked to her termination.
-
January 29, 2026
Healthcare Group Of The Year: Bass Berry
Bass Berry & Sims PLC's recent work advising Sycamore Partners on its $23.7 billion acquisition of Walgreens Boots Alliance, taking the pharmacy retailer off the public market, has earned the firm a spot among the 2025 Law360 Healthcare Groups of the Year.
-
January 28, 2026
Biogen Can't Escape Amended Antitrust Suit Over MS Drug
Biogen Inc. must face health plans' claims that it bribed pharmacy benefit managers to stifle generics competition for its multiple sclerosis drug Tecfidera, after an Illinois federal judge found Wednesday that the plans' latest amended complaint in their consolidated antitrust litigation corrects her prior concerns with the pleadings.
-
January 28, 2026
Ambulance Billing Co. Settles Data Breach Claims
An ambulance billing service will pay a total of $515,000 to the states of Massachusetts and Connecticut and take measures to improve its data security to settle allegations stemming from a 2022 breach, the Massachusetts Attorney General's Office announced Wednesday.
-
January 28, 2026
NM Bill Could Shield Medical Cannabis Users From Job Bias
Democratic lawmakers in New Mexico's Legislature are looking to redefine employment rules for medical cannabis patients to prohibit bosses from taking adverse actions for lawful off-duty use but allow them to restrict use for certain roles or carry out discipline for impairment at work.
-
January 28, 2026
Fla. Court Undoes Class Cert. Of Medicare Cos. In USAA Suit
A Florida state appeals court on Wednesday reversed class certification for a group of Medicare-contracted businesses suing USAA Casualty Insurance Co. over allegations the insurer sidestepped its obligation to pay automobile injury claims and passed them on to so-called secondary payers.
-
January 28, 2026
NY Firm And Medical Providers Defrauded Insurers, Suit Says
An insurer accused a law firm and a collection of medical providers and professionals of engaging in a scheme to defraud insurers through sham lawsuits and inflated medical bills, telling a New York federal court that the defendants have enriched themselves "at the expense of justice, equity and human dignity."
-
January 28, 2026
BlackRock, Eclipse Lead Cellares' $257M Funding Round
Integrated development and manufacturing organization company Cellares, which focuses on the large-scale manufacturing of cell therapies, on Wednesday announced that it closed a $257 million funding round, bringing the South San Francisco, California-based company's total capital raised to $612 million.
-
January 28, 2026
ArentFox Schiff Launches Longevity Industry Group
ArentFox Schiff LLP on Wednesday announced the launch of a group geared toward advising companies focused on advancing wellness, preventive health care and the longevity of life.
-
January 28, 2026
Employee Exodus Prompts CEO Defamation Lawsuit
Employees moving from one Turkish company to another has led to a $5.5 million defamation lawsuit between the CEOs of their American affiliates, according to a complaint filed in a federal court in Pennsylvania.
-
January 28, 2026
Healthcare Group Of The Year: McDermott
McDermott Will & Schulte attorneys advised Northwell Health hospital and health system through its integration with Nuvance Health and represented Lee Equity Partners and Solaris Health in the $1.9 billion sale of Solaris to Cardinal Health Platform, The Specialty Alliance, earning it a spot among the 2025 Law360 Healthcare Practice Groups of the Year.
-
January 28, 2026
False Claims Expert Moves Philly Practice To Holland & Knight
Increased activity in litigation involving health care law and the False Claims Act has prompted a Philadelphia attorney to move her practice to Holland & Knight LLP after nearly 20 years at Morgan Lewis & Bockius LLP.
-
January 28, 2026
Generics Makers Want Hospital Drug Data In Price-Fixing MDL
A group of 150 hospitals suing generic-drug makers for alleged price fixing in multidistrict litigation should hand over data on their drug purchases, the drugmakers have told a Pennsylvania federal court, arguing they don't sell directly to the hospitals and therefore have no records themselves.
-
January 28, 2026
GAO Dismisses Ohio Co.'s Challenge To VA Bid Rejection
The U.S. Government Accountability Office said an Ohio company's disagreement with a U.S. Department of Veterans Affairs decision to reject its bid for a medical center renovation over performance concerns belonged with the Small Business Administration.
-
January 28, 2026
Call Center Workers Ink Wage Deal With Disability Nonprofit
A disability services nonprofit has agreed to pay $76,500 to settle a suit accusing it of failing to pay call center employees for work before shifts and during unpaid meal breaks and of miscalculating their overtime, the workers told a Virginia federal court.
-
January 27, 2026
Ohio PBM Suit Belongs In Federal Court, 6th Circ. Rules
The Sixth Circuit on Tuesday ruled that Ohio's lawsuit accusing pharmacy benefit managers of driving up prescription prices through rebate schemes belongs in federal court, saying in an opinion recommended for publication that the suit imposes liability on conduct undertaken at the direction of a federal officer.
-
January 27, 2026
Lasik Provider Can't Shake Wiretap Claims In Tracking Row
The operator of a laser eye surgery website must face a proposed class action alleging it illegally shared patients' confidential medical information with Meta, a California federal judge ruled, finding that the plaintiff could continue to press allegations under state and federal wiretap law.
Expert Analysis
-
Opinion
Despite Deputy AG Remarks, DOJ Can't Sideline DC Bar
Deputy Attorney General Todd Blanche’s recent suggestion that the D.C. Bar would be prevented from reviewing misconduct complaints about U.S. Department of Justice attorneys runs contrary to federal statutes, local rules and decades of case law, and sends the troubling message that federal prosecutors are subject to different rules, say attorneys at HWG.
-
Unique Aspects Of Texas' Approach To AI Regulation
The Texas Responsible AI Governance Act — which will soon be the sole comprehensive artificial intelligence law in the U.S. — pulls threads from EU and Colorado laws but introduces more targeted rules with fewer obligations on commercial entities, say attorneys at MVA Law.
-
3 Takeaways From FDA Cell And Gene Therapy Draft Guidance
The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.
-
Rule Amendments Pave Path For A Privilege Claim 'Offensive'
Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.
-
IP Ownership Risk Grows In Booming Cancer Drug Market
The ownership of intellectual property has become strategically decisive in deals involving valuable cancer therapeutics known as ADCs, as highlighted by the recent Takeda-Innovent deal, with the commercial value of a license resting on the integrity and defensibility of the underlying technology, say attorneys at Loeb & Loeb.
-
Series
My Miniature Livestock Farm Makes Me A Better Lawyer
Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.
-
Surveying The Healthcare Policy Landscape Post-Shutdown
With last week's agreement to reopen the federal government, at least through the end of January, key healthcare legislation that has been in limbo since a December 2024 spending bill fell apart may recapture the attention of Congress, say attorneys at Faegre Drinker.
-
FDA Biosimilar Guidance Should Ease Biologics Development
New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.
-
Litigation Funding Could Create Ethics Issues For Attorneys
A litigation investor’s recent complaint claiming a New York mass torts lawyer effectively ran a Ponzi scheme illustrates how litigation funding arrangements can subject attorneys to legal ethics dilemmas and potential liability, so engagement letters must have very clear terms, says Matthew Feinberg at Goldberg Segalla.
-
E-Discovery Quarterly: Recent Rulings On Dynamic Databases
Several recent federal court decisions illustrate how parties continue to grapple with the discovery of data in dynamic databases, so counsel involved in these disputes must consider how structured data should be produced consistent with the requirements of the Federal Rules of Civil Procedure, say attorneys at Sidley.
-
Prison Body Cams Raise Health Privacy Compliance Issues
The increasing use of prison staff body cameras to enhance transparency and safety presents correctional healthcare partners with new risk management questions where they must carefully reconcile the benefits of surveillance with the imperative to protect patient privacy, say attorneys at Gordon Rees.
-
Series
Building With Lego Makes Me A Better Lawyer
Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.
-
Series
Law School's Missed Lessons: Networking 101
Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.
-
Defeating Estoppel-Based Claims In Legal Malpractice Actions
State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.
-
How Cos. Can Prep For Tightened Calif. Data Breach Notices
Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.